Match!
Claire Liefferinckx
Université libre de Bruxelles
Inflammatory bowel diseaseUstekinumabCrohn's diseaseDiabetes mellitusMedicine
21Publications
3H-index
21Citations
What is this?
Publications 26
Newest
#2P. M. M. BossuytH-Index: 110
Last. Denis FranchimontH-Index: 47
view all 11 authors...
Source
#1S Di Stefano (University of Verona)
Last. Alexis BuggenhoutH-Index: 7
view all 9 authors...
Source
#1Uri Kopylov (Sheba Medical Center)H-Index: 31
Last. David DrobneH-Index: 6
view all 34 authors...
Source
Source
Source
#1Anneline Cremer (ULB: Université libre de Bruxelles)H-Index: 3
#2Jade Ku (ULB: Université libre de Bruxelles)H-Index: 1
Last. Denis Franchimont (ULB: Université libre de Bruxelles)H-Index: 47
view all 11 authors...
1 CitationsSource
#2Bram Verstockt (Katholieke Universiteit Leuven)H-Index: 11
Last. Severine Vermeire (Katholieke Universiteit Leuven)H-Index: 110
view all 19 authors...
Source
#2Leila AmininejadH-Index: 9
Last. A. Van GossumH-Index: 33
view all 8 authors...
Source
#2Bram VerstocktH-Index: 11
Last. Severine VermeireH-Index: 110
view all 19 authors...
Source
#2Bram Verstockt (Katholieke Universiteit Leuven)H-Index: 11
Last. Denis FranchimontH-Index: 47
view all 7 authors...
BackgroundVery little is known about the impact of the wash-out period on the pharmacokinetics of a second-line biologic.ObjectiveThe objective of this article is to explore the impact of two diffe...
Source
123